by Brad N. Taylor, Ph.D. | Aug 31, 2022
Cell and gene therapy products are only as good as their cellular building blocks— therefore cell culture media should first and foremost be designed to support consistent and optimal cellular performance. Welcome to Part 2 of our blog series highlighting...
by Brad N. Taylor, Ph.D. | May 24, 2022
Nucleus Biologics, together with its spinoff company Stoic Bio, is reimagining cell culture media manufacturing to bring the pharmaceutical industry a system that can deliver custom media in a sustainable manner-all while lowering the total delivered cost. In our...
by Brad N. Taylor, Ph.D. | Apr 6, 2022
Scaling up cell culture media for your cellular therapy doesn’t have to be grueling; Nucleus Biologics simplifies formulation testing, scale-up, and re-ordering to make your life easier. Last week, we discussed media potency and how changing even one cell culture...
by Brad N. Taylor, Ph.D. | Mar 8, 2022
Nucleus Biologics recently announced the distribution of Krakatoa™, a point-of-use media manufacturing system aimed at improving the industry’s environmental impact. Nucleus Biologics plans to cure people + planet. Not many biologics companies have such bold goals,...
